NDXP241122C21250000
- 0.03
- 0.000.00%
NASDAQ 100 Index Newsroom
U.S. stock market outlook: Bullish on weight loss drugs concept stocks! eli lilly and co, novo-nordisk a/s rose more than 4% in pre-market trading; Tesla's rival Rivian rose 10% in pre-market trading, approved for a loan of $6.6 billion.
Growth tech stocks rose overall before the market opened, with nvidia and AMD up 1%; cryptos concept stocks collectively fell, with MARA and cleanspark down over 5%.
Amgen Reveals Data From Closely Watched Monthly Obesity Drug, With Weight Loss Of Up To 20% At One Year And No Plateau
Jim Cramer: Linde Is A 'Terrific' Company, Sees Another Stock Up 75% As 'Not Done'
The Trump Cabinet 2.0 "Dream Team" is unveiled! Understand the economic views of the officials in one image.
The major team of Trump's Cabinet 2.0 has gradually taken shape, characterized by: first, loyalty is prioritized, and overall policy inclination is largely consistent with Trump; second, many candidates come from the business and financial sectors; third, the attitude towards China is generally tough.
Stifel Maintains Hold on Marriott Intl, Raises Price Target to $283
Marriott Intl Analyst Ratings
Trump's close adviser is accused of seeking money from potential officials, conflicting with Musk and Bezos.
① Multiple sources have revealed that Trump's senior legal advisor Boris Epshteyn allegedly asked for 'consultation fees' from individuals wishing to take up government positions, prompting an investigation ordered personally by Trump; ② Trump's team spokesperson Steven Zhang stated that an internal review has been completed, but did not disclose specific results; ③ Trump has expressed strong disdain for such behavior that exploits his name for personal gain.
Marvell Tech Analyst Ratings
Amgen's weight loss drug can reduce weight by 20% in one year, but Wall Street is still not satisfied, causing a sharp drop in stock prices.
① The experimental obesity treatment drug MariTide from the usa pharmaceutical company amgen can help obese patients lose an average of up to 20% of their weight after one year of use, but the stock price plummeted due to data falling short of Wall Street expectations. ② Amgen claims that MariTide can lead to faster weight loss, maintain weight, and require fewer injections, but analysts question its potential side effects on bone density.
Domino's, Vertiv, MercadoLibre And More On CNBC's 'Final Trades'
Analog Devices Declares $0.92 Dividend
Zoom's Tumble Leaves Mixed Picture for Collaboration Software
The Federal Reserve meeting minutes and PCE price index are coming one after another! They may provide the latest clues for the market regarding interest rate cuts.
According to cme's 'Fed Watch', the probability of the Fed keeping the current interest rate unchanged until December is 44.1%, while the cumulative probability of a 25 basis point rate cut is 55.9%.
Starbucks Analyst Ratings
Analog Devices Shares Are Trading Higher After the Company Reported Better-than-expected Q4 EPS and Sales.
Analog Devices Shares Are Trading Higher After the Company Reported Better-than-expected Q4 Financial Results.
Amgen Shares Are Trading Lower Following the Results of Its Phase 2 Study With MariTide in Obesity.
Amgen Announced Data At 52 Weeks In Phase 2 Study With MariTide (Maridebart Cafraglutide, Formerly AMG 133) Subcutaneously Administered Monthly Or Less Frequently, Showing Up To ~20% Average Weight Loss At Week 52 Without A Weight Loss Plateau
Finally confirmed! The Biden administration's subsidy to intel has "shrunk" to 7.9 billion dollars.
① The Biden administration has finalized a $7.86 billion chip subsidy agreement for intel, which is a reduction from the originally planned $8.5 billion; ② This means that intel will soon receive funding, and the company is expected to qualify for at least $1 billion in funding this year.
Trump Looks to Appoint 'AI Czar' to Oversee AI Policy Efforts - Report